Search research articles
Contact Us
Filters
Showing results (601-610 of 618) with videos related to
Page
of 62
Sort By:
The International Journal of Neuropsychopharmacology
|
April 3, 2020
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
Lawrence T Park, Bashkim Kadriu, Todd D Gould, et al.
The Journal of Clinical Investigation
|
August 3, 2007
AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons
Marc Claret, Mark A Smith, Rachel L Batterham, et al.
Cell Metabolism
|
November 4, 2009
Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons
Hind Al-Qassab, Mark A Smith, Elaine E Irvine, et al.
The Journal of Biological Chemistry
|
March 12, 2011
Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain
Wen-Quan Zou, Xiangzhu Xiao, Jue Yuan, et al.
Scientific Reports
|
February 27, 2016
Dedicated Industrial Oilseed Crops as Metabolic Engineering Platforms for Sustainable Industrial Feedstock Production
Li-Hua Zhu, Frans Krens, Mark A Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors
Anthony D Pechulis, James P Beck, Matt A Curry, et al.
Free Radical Biology & Medicine
|
February 22, 2005
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Quan Liu, Mark A Smith, Jesus Avilá, et al.
Scientific Reports
|
August 13, 2013
Strong temporal variation over one Saturnian year: from Voyager to Cassini
Liming Li, Richard K Achterberg, Barney J Conrath, et al.
Frontiers in Psychiatry
|
January 24, 2022
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
Mark A Smith, Shannon L Ballard, Clarise F Ballesteros, et al.
Journal of Neurochemistry
|
May 20, 2003
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
Etsuro Matsubara, Tara Bryant-Thomas, Javier Pacheco Quinto, et al.
Page
of 62
Search research articles
Search
Showing results (601-610 of 618) with videos related to
Sort By:
Page
of 62
The International Journal of Neuropsychopharmacology
|
April 3, 2020
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
Lawrence T Park, Bashkim Kadriu, Todd D Gould, et al.
The Journal of Clinical Investigation
|
August 3, 2007
AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons
Marc Claret, Mark A Smith, Rachel L Batterham, et al.
Cell Metabolism
|
November 4, 2009
Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons
Hind Al-Qassab, Mark A Smith, Elaine E Irvine, et al.
The Journal of Biological Chemistry
|
March 12, 2011
Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain
Wen-Quan Zou, Xiangzhu Xiao, Jue Yuan, et al.
Scientific Reports
|
February 27, 2016
Dedicated Industrial Oilseed Crops as Metabolic Engineering Platforms for Sustainable Industrial Feedstock Production
Li-Hua Zhu, Frans Krens, Mark A Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors
Anthony D Pechulis, James P Beck, Matt A Curry, et al.
Free Radical Biology & Medicine
|
February 22, 2005
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Quan Liu, Mark A Smith, Jesus Avilá, et al.
Scientific Reports
|
August 13, 2013
Strong temporal variation over one Saturnian year: from Voyager to Cassini
Liming Li, Richard K Achterberg, Barney J Conrath, et al.
Frontiers in Psychiatry
|
January 24, 2022
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
Mark A Smith, Shannon L Ballard, Clarise F Ballesteros, et al.
Journal of Neurochemistry
|
May 20, 2003
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
Etsuro Matsubara, Tara Bryant-Thomas, Javier Pacheco Quinto, et al.
Page
of 62